본문 바로가기
KERD
논문KCI 등재후보

The PROTECTIVE Effect of White Beech Mushroom(Hypsizygus Marmoreus) Extract against Atopic Dermatitis Skin Lesion Model using NC/Nga Mice

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류학제간연구

초록

Purpose: This study was carried out to evaluate the protective effects of Hypsizygus marmoreus extract against sodium dodecyl sulfate-induced atopic dermatitis-like skin lesions in vivo. Methods: Six-week-old NC/Nga mice were divided into a control group(Ctrl), atopic dermatitis induction group(ADIG), and H. marmoreus extract feeding group after atopic dermatitis induction(HTFG). After 3 weeks, cannabinoid receptors type 1(CB1) and type 2(CB2), and the orphan G protein-coupled receptor 55(GPR55) levels were observed to verify the modulation of the endocannabinoid system activity, whereas filaggrin and kallikrein-related peptidase(KLK) 7 expression in the stratum corneum and protease activated receptor(PAR)-2 expression in the interstitial space of epithelial tissue were observed to verify the inhibition of inflammation. Furthermore, phosphorylated extracellular signal-related kinase(p-ERK), phosphorylated mammalian target of rapamycin(p-mTOR), and E-cadherin levels were studied to verify microenvironmental regulation. Results: Expression of CB1, CB2, and GPR55 was significantly increased in HTFG as compared to that in ADIG. The positive reaction of filaggrin in the stratum corneum was significantly higher in HTFG than in ADIG. KLK7 and PAR-2 positivity in HTFG were significantly reduced as compared to those in ADIG. The p-ERK-positive and p-mTOR-positive reactions in HTFG were significantly reduced as compared to those in ADIG. Conclusion: H. marmoreus extract has a beneficial effect on the epithelium barrier function and can inhibit the progression of atopic dermatitis.

Abstract

Purpose: This study was carried out to evaluate the protective effects of Hypsizygus marmoreus extract against sodium dodecyl sulfate-induced atopic dermatitis-like skin lesions in vivo. Methods: Six-week-old NC/Nga mice were divided into a control group(Ctrl), atopic dermatitis induction group(ADIG), and H. marmoreus extract feeding group after atopic dermatitis induction(HTFG). After 3 weeks, cannabinoid receptors type 1(CB1) and type 2(CB2), and the orphan G protein-coupled receptor 55(GPR55) levels were observed to verify the modulation of the endocannabinoid system activity, whereas filaggrin and kallikrein-related peptidase(KLK) 7 expression in the stratum corneum and protease activated receptor(PAR)-2 expression in the interstitial space of epithelial tissue were observed to verify the inhibition of inflammation. Furthermore, phosphorylated extracellular signal-related kinase(p-ERK), phosphorylated mammalian target of rapamycin(p-mTOR), and E-cadherin levels were studied to verify microenvironmental regulation. Results: Expression of CB1, CB2, and GPR55 was significantly increased in HTFG as compared to that in ADIG. The positive reaction of filaggrin in the stratum corneum was significantly higher in HTFG than in ADIG. KLK7 and PAR-2 positivity in HTFG were significantly reduced as compared to those in ADIG. The p-ERK-positive and p-mTOR-positive reactions in HTFG were significantly reduced as compared to those in ADIG. Conclusion: H. marmoreus extract has a beneficial effect on the epithelium barrier function and can inhibit the progression of atopic dermatitis.

참고문헌 (50)

  1. 손성한, "황련해독탕의 피부지방장벽개선을 통한 Th2 분화조절이 아토피피부염 완화에 미치는 효과", 대한한방소아과학회지, 32(3), pp.90~99 (2018), 대한한방소아과학회[DOI]
  2. Leung DY, "New Insights into Atopic Dermatitis", The Journal of Clinical Investigation, 113(5), pp.651~657 (2004)
  3. Engel-Yeger B, "Sensory Processing Patterns of Adults with Atopic Dermatitis", Journal of the European Academy of Dermatology and Venereology, 25(2), pp.152~156 (2011)
  4. 안강모, "2010년 한국 어린이·청소년의 천식, 알레르기 비결막염, 아토피피부염 증상 유병률 조사: 복합표본설계를 이용한 전국 서베이", 대한의사협회지, 54(7), pp.769~778 (2011), 대한의사협회
  5. Kabashima K, "New Concept of the Pathogenesis of Atopic Dermatitis : Interplay among the Barrier, Allergy, and Pruritus as a Trinity", Journal of Dermatological Science, 70(1), pp.3~11 (2013)
  6. 박양, "한국에서 아토피피부염 진단과 치료의 임상적 실태 조사", Allergy Asthma & Respiratory Disease, 1(3), pp.257~265 (2013), 대한 소아알레르기 호흡기학회
  7. Callen J, "A Systematic Review of the Safety of Topical Therapies for Atopic Dermatitis", British Journal of Dermatology, 156(2), pp.203~221 (2007)
  8. Pariser D, "Topical orticosteroids and Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis : Focus on Percutaneous Absorption", American Journal of Therapeutics, 16(3), pp.264~273 (2009)
  9. Babicek K, "Toxicological Assessment of a Particu-late Yeast(1 &3", 1, 6)-beta-D-glucan in Rats, 2007, pp.45(9), 1719~1730
  10. Delaney B, "Beta-glucan Fractions from Barley and Oats are Similarly Antiathero-genic in Hypercholesterolemic Syrian Golden Hamsters", The Journal of Nutrition, 133(2), pp.468~475 (2003)
  11. Delatte SJ, "Effectiveness of Beta-glucan Collagen for Treatment of Partial-thickness Burns in Children", Journal of Pediatric Surgery, 36(1), pp.113~118 (2001)
  12. Hetland G, "Protective Effect of β-glucan against Systemic Streptococcus Pneumonia Infection in Mice", FEMS Immunology & Medical Microbiology, 27(2), pp.111~116 (2000)
  13. Nicolosi R, "Plasma Lipid Chang-es after Supplementation with Beta-glucan Fiber from Yeast", The American Journal of Clinical Nu-trition, 70(2), pp.208~212 (1999)
  14. Chan GC, "The Effects of Beta-glucan on Human Immune and Cancer cells", Journal of Hematology & Oncology, 2(25), pp.1~11 (2009)
  15. 김인성, "아토피 피부염 모델에 대한 β-1,3", 1,6-glucan과 Lactobacillus plantarum LM1004의 면역조절 효과, 2018, pp.28(1), 17~25[DOI]
  16. 금보람, "인간 단핵구 THP-1 세포에서 β-glucan으로 인한 TNF-α 분비 증가 효과", 생명과학회지, 27(11), pp.1256~1261 (2017), 한국생명과학회
  17. Yu CS, "A Study of the Safety and Effect of Products Containing Ceramide, Glucan for Atopic Dermatitis", Journal of Society of Cosmetic Scientists of Korea, 30(4), pp.533~541 (2004)
  18. Manzanares J, "Role of the Cannabinoid System in Pain Control and Therapeutic Implications for the Management of Acute and Chronic Pain Episodes", Current Neu-ropharmacology, 4(3), pp.239~257 (2006)
  19. Pacher P, "The Endocannabinoid System as an Emerging Target of Phar-macotherapy", Pharmacological Reviews, 58(3), pp.389~462 (2006)
  20. Miller LK, "The Highs and Lows of Cannabinoid Receptor Expression in Disease : Mech-anisms and Their Therapeutic Implications", Pharmacological Reviews, 63(3), pp.461~470 (2011)
  21. Luger TA, "Neuromediators-a Crucial Component of the skin Immune system", Journal of Derma-tological Science, 30(2), pp.87~93 (2002)
  22. Seo Il-bok, "A Korean Poly-Herbal Medicine, SMO16, Regulates the RANKL", OPG Bone Remodeling in OVX Rat Model, 2020, pp.5(1), 58~64[DOI]
  23. Kang Hye-ra1, "A SPORTS Nutrition Supplement, Albizia Julibrissin Extract Fermented with Kefir Yogut Regulates Lipopolysaccharideinduced Inflammatory Signal", Kinesiology, 4(2), pp.1~6 (2019), J-INSTITUTE
  24. Seo Il-bok, "Effect of SMO16, a KOREAN Poly-Herbal Medicine, on Bone Mass in Ovariectomized Rat", Kinesiology, 2(2), pp.18~22 (2017), J-INSTITUTE
  25. Yoon Tae-gun, "A Candidate SPORTS Nutrition Supplement, Lonicerae Flos, Attenuates Collagen-Induced Arthritis in Mice", Kinesiology, 1(2), pp.1~5 (2016), J-INSTITUTE
  26. Choi Nan-hee, "Protective Effect of Cynanchum Wilfordii Root Crude Extract on Acetaminophen-Induced Liver Toxicity", Kinesiology, 2(1), pp.1~6 (2017), J-INSTITUTE
  27. Peng W, "Pathogenesis of Atopic Dermatitis", Clinical and Experimental Allergy, 45(3), pp.566~574 (2015)
  28. Spergel J, "Atopic Dermatitis and the Atopic March", Journal of Allergy and Clinical Immunology, 112(6), pp.S118~S127 (2003)
  29. Kabashima K, "New Concept of the Pathogenesis of Atopic Dermatitis : Interplay Among the Bar-rier, Allergy, and Pruritus as a Trinity", Journal of Dermatological Science, 70(1), pp.3~11 (2013)
  30. Lee HY, "Improvement of Skin Barrier Dysfunction by Scutellaria Baicalensis Geogi Extracts through Lactic-acid Fermentation", Journal of Cosmetic Dermatology, 18(1), pp.183~191 (2019)
  31. Imokawa G, "Decreased Level of Ceramides in Stratum Corneum of Atopic Dermatitis: An Etiologic Factor in Atopic Dry Skin?", Jour-nal of Investigative Dermatology, 96(4), pp.523~526 (1991)
  32. Jensen JM, "Impaired Sphingomyelinase Activity and Epidermal Differentiation in Atopic Dermatitis", Journal of Investigative Dermatology, 122(6), pp.1423~1431 (2004)
  33. Schafer M, "Cancer as an Overhealing Wound : An Old Hypothesis Revisited", Nature Reviews Molecular Cell Biology, 9(8), pp.628~638 (2008)
  34. Toth BI, "Endocannabinoids´ Modulate Human Epidermal Keratinocyte Proliferation and Survival via the Sequential Engagement of Cannabinoid Receptor-1 and Transient receptor Poten-tial Vanilloid-1", Journal of Investigative Dermatology, 131(5), pp.1095~1104 (2011)
  35. Kupczyk P, "Cannabinoid System in the Skin-a Possible Target for Future Therapies in Dermatology", Experimental Dermatology, 18(8), pp.669~679 (2009)
  36. Salzet M, "Invertebrate Molecular Neuroimmune Processes", Brain Res Reviews, 34(1-2), pp.69~79 (2000)
  37. Yang H, "GPR55-A Putative “Ttype 3” Cannabinoid Receptor in Inflamma-tion", Journal of Basic Clinical Physiology and Pharmacology, 27(3), pp.297~302 (2016)
  38. Kim HJ, "Topi-cal Cannabinoid receptor 1 Agonist Attenuates the Cutaneous Inflammatory Responses in Oxazo-lone-induced Atopic Dermatitis Model", International Journal of Dermatology, 54(10), pp.401~408 (2015)
  39. 남개원, "Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model", Annals of Dermatology, 28(1), pp.22~29 (2016), 대한피부과학회
  40. Gaffal E, "Anti-inflammatory Activity of Topical THC in DNFB-mediated Mouse Allergic Contact Dermatitis Independent of CB1 and CB2 Receptors", Allergy, 68(8), pp.994~1000 (2013)
  41. Haruna T, "The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Ago-nist, on Skin Inflammation in Mice", Pharmacology, 99(5-6), pp.259~267 (2017)
  42. Cantarella G, "Endocanna-binoids inhibit Release of Nerve Growth Factor by Inflammation-activated Mast cells", Biochemical Pharmacology, 82(4), pp.380~388 (2011)
  43. Lambers H, "Natural Skin Surface pH is on Average Below 5, Which is Beneficial for Its Residential Flora", International Journal of Cosmetic Science, 28(5), pp.359~370 (2006)
  44. 김현정, "아토피피부염과 피부 장벽 이상", Allergy Asthma & Respiratory Disease, 1(1), pp.20~28 (2013), 대한 소아알레르기 호흡기학회
  45. 최응호, "아토피피부염의 병인", 대한의사협회지, 57(3), pp.218~225 (2014), 대한의사협회[DOI]
  46. Chen JQ, "Roles of Kallikrein-related Peptidase in Epider-mal Barrier Function and Related Skin Diseases", International Journal of Dermatology and Vene-reology, 2(3), pp.150~155 (2019)
  47. Yamamoto M, "Kallikrein-related Peptidase-7 regulates Caspase-14 Maturation during Keratinocyte Terminal Differentiation by Generating an Intermediate Form", Journal of Biological Chemistry, 287(39), pp.32825~32834 (2012)
  48. Buerger C, "Inflammation Dependent mTORC1 Signaling Interferes with the Switch from Keratinocyte Prolif-eration to Differentiation", PLoS One, 12(7), pp.e0180853~ (2017)
  49. Yang F, "Topical Application of Rapamycin Ointment Ameliorates Dermatopha-goides Farina Body Extract-induced Atopic Dermatitis in NC", Nga Mice, 2014, pp.23(8), 568~572
  50. Trautmann A, "The Differential Fate of Cadherins during T-cell-induced Keratinocyte Apoptosis Leads to Spongiosis in Eczematous Dermatitis", Journal of Investigative Dermatology, 117(4), pp.927~934 (2001)

관련 논문AI추천

이 간행물의 다른 논문 (9건)